Fig. 2.
Risk of congenital malformations in infants, according to maternal exposure to SSRIs. Relative risks and 95% confidence intervals are presented to show the risk of congenital malformations among infants born to women with exposure to SSRIs during the first trimester, as compared with the risk among infants born to women in the general population without such exposure. SSRIs, selective serotonin reuptake inhibitors